Red blood cells (RBCs) are key players in systemic oxygen transport. RBCs respond to in vitro hypoxia through the so-called oxygen-dependent metabolic regulation, which involves the competitive binding of deoxyhemoglobin and glycolytic enzymes to the N-terminal cytosolic domain of band 3. This mechanism promotes the accumulation of 2,3-DPG, stabilizing the deoxygenated state of hemoglobin, and cytosol acidification, triggering oxygen off-loading through the Bohr effect. Despite in vitro studies, in vivo adaptations to hypoxia have not yet been completely elucidated.
Introduction
Understanding systemic adaptations to hypoxia is a challenging task, one of relevance to a broad community of researchers and clinicians involved in cardiovascular research, 1 pulmunology 2 , transfusion medicine, 3 and intesive care medicine 4 . Of note, unraveling the mechanisms of adaptation to hypoxia might influence our understanding of evolutionary adaptations as extreme as mammalian hibernation, 5 a poorly understood phenomenon that holds potential clinical, military or space-travel translational applications 6 . Other than for clinical/research purposes, understanding systemic adaptations to hypoxia might also influence the daily lives of millions of healthy people around the world. Approximately 140 million people live permanently, or travel to high altitudes (>2500 m) in North, Central and South America, East Africa, and Asia. 7 Many people successfully adjust to the hypoxic environment at very high altitudes (~5000 m), where oxygen pressures are about half of those registered at sea level.
Despite decades of strides in the field [8] [9] [10] [11] [12] [13] [14] , the current mechanistic understanding of human in vivo adaptations to hypoxia is still incomplete. Undoubtedly, red blood cells (RBCs) play a clear role in adaptations to hypoxia, in line with their vital role in oxygen transport and delivery. [8] [9] [10] [11] [12] [13] [14] Increases in red cell volume (RCV) and total hemoglobin mass (Hbmass) are observed as early as one or two weeks after exposure to high altitude, even though these adaptations are eventually lost following descent to low altitude. 14, 15 Besides, while hypoxia can induce systemic increase of erythropoietin (EPO) levels within hours of hypobaric hypoxia 16 , EPO-stimulated production of mature RBCs from the bone marrow can take days to occur. 17 Cellular adaptations to hypoxia also involve the stabilization of hypoxia-inducible factors (HIFs), a family of transcriptional factors 18 involved in metabolic regulation, as it is increasingly emerging in cancer 19 and pulmonary hypertension. 20 HIF degradation is mediated through HIF hydroxylation by O 2 -sensing protein hydroxylases (PHDs). 19 Mutations of PHD2 21 results in decreased degradation of HIF1α, that in turn transcriptionally regulates numerous metabolic enzymes 22 , thereby contributing to adaptive metabolic responses to hypoxia such as increased erythropoiesis 21 in patients carrying the mutation. At the same time, hypoxia-induced uncoupling of the electron transport chain promotes increases in the levels of Krebs cycle intermediates, which in turn promote the stabilization of HIF1α through the direct inhibition of PHDs, suggesting a crosstalk between metabolic adaptation and gene expression phenotypes under hypoxia. 23 Decades of laboratory studies aimed at understanding RBC responses to deoxygenation and hypoxia have fostered great advances in structural and functional biochemistry, introducing the concept of allosteric modulation 24 . Over the years, structural and functional evidence has been produced about the hypoxia-dependent promotion of hemoglobin oxygen off-loading through the stabilization of the deoxygenated tense state (T) by negatively charged high phosphate compounds adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (DPG) 8 . In the last twenty years, the model has been expanded as to introduce the concept of the "transport metabolon", which involves band 3. As the most abundant RBC membrane protein (1×10 6 copies/cell), band 3 modulates CO 2 gas transport in erythrocytes through the so-called "chloride shift" (HCO 3 − /Cl − exchange), thereby contributing to pH homeostasis and oxygen off-loading by promoting the "Bohr effect". 25 The "transport metabolon" model is based on the observation that the N-terminal cytosolic domain of band 3, which contains numerous acidic residues, might stabilize deoxyhemoglobin through direct binding. [26] [27] [28] [29] However, the N-terminal region of band 3 also serves as a docking site for key glycolytic enzymes, including phosphofructokinase (PFK), aldolase (ALDO) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). These enzymes are functionally inhibited by binding to band 3 at high oxygen saturation, thereby promoting late glycolytic blockade and a shift towards the anti-oxidant NADPH-generating pentose phosphate pathway (PPP). [26] [27] [28] [29] Binding of deoxyhemoglobin to band 3 promotes the displacement and activation of late glycolytic enzymes, thus favoring glycolysis. [26] [27] [28] [29] According to this model, [26] [27] [28] [29] as much as 92% of glucose is catabolized through the classic Embden-Meyerhoff glycolytic pathway under normoxia, while anoxia triggers consumption of as much as 90% of glucose via the PPP. This model has been supported by in vitro evidence 30 and in silico prediction based on metabolomics data of ex vivo aging RBCs under anaerobic conditions 31, 32 . However, evidence of in vivo RBC metabolic adaptations to hypoxia has not been hitherto produced.
Here we hypothesize that exposure to high-altitude hypoxia triggers dramatic metabolic modulation of RBCs in humans. These metabolic adaptations might underlie adaptations to high altitude hypoxia, a phenomenon that is partially retained upon later re-ascent. 33 RBC metabolic phenotypes have been here correlated to physiological tests, as to understand whether metabolic adaptations might at least partially explain retention of improved performances upon adjustment to hypoxia during second ascents.
Methods
The study was performed as part of the AltitudeOmics research program, as previously reported 15, [33] [34] [35] [36] [37] [38] [39] on the first, seventh and sixteenth days at 5260 m (ALT1, ALT7, ALT16; n=20), and again upon reascent to 5260 m, after 7 (n = 14) days at low altitude (POST). Subjects breathed supplemental oxygen (2 L/min, nasal cannula or mask) during the drive for the first ascent to 5260 m.
Blood processing and metabolomics extraction
Whole blood was drawn from an antecubital venous catheter and immediately processed to sort plasma and cell components at the same time of the day (noon) at SL, and on ALT1, 7, 16 and POST at high altitude. RBCs were snap frozen in liquid nitrogen and stored at −80°C prior to metabolomics analyses. RBCs (100 μl) were extracted in lysis/extraction buffer (methanol:acetonitrile:water 5:3:2, −20°C) at 1:9 dilution, as previously reported 40 . Samples were vortexed at 4°C for 30 min and then centrifuged at 10,000g for 15min at 4°C to pellet proteins and collect the supernatants for metabolomics analyses.
Metabolomics analysis
RBC extracts (10 μl) were injected into an UHPLC system (Ultimate 3000, Thermo, San Jose, CA, USA) and run on a a Kinetex XB-C18 column (150×2.1 mm i.d., 1.7 μm particle size -Phenomenex, Torrance, CA, USA), as reported 41 . MS analyses through a QExactive mass spectrometer (Thermo, San Jose, CA, USA) and metabolite identification through Maven 42 (Princeton, NJ, USA), the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database, and a library of >800 standard compounds (SIGMA Aldrich, St. Louis, MO, USA; MLSMS, IROATech, Bolton, MA, USA) were performed as reported 40, 41 .
Measurements of nitrite, nitrate, S-NO and H 2 S
Methods for the measurement of nitrate (NO 3 − ) and nitrite (NO 2 − ) and H 2 S were performed as extensively reported. 43, 44 
Statistical Analysis
Integrated peak area values were exported into Excel (Microsoft, Redmond, CA, USA) for statistical analysis including T-Test and ANOVA (significance threshold for p-values < 0.05; false discovery rate cutoffs set to 0.01 for initial screening and 0.05 for time point-specific comparisons) and partial least square discriminant analysis (PLS-DA), calculated through the macro MultiBase (freely available at www.NumericalDynamics.com). To exclude overfitting of PLS-DA elaboration, we repeated the clustering analysis by performing random permutations. Hierarchical clustering analysis (HCA) was performed through the software GENE-E (Broad Institute, Cambridge, MA, USA). Pearson's correlations and XY graphs were calculated and plotted through GraphPad Prism 5.0 (GraphPad Software Inc., La Jolla, CA, USA). Figure panels were assembled through Photoshop CS5 (Adobe, Mountain View, CA, USA).
Results
A total of 229 metabolites were monitored in RBC extracts from 21 subjects enrolled in this study at sea leavel, or 1, 7 and 16 days at high altitude, or upon ascending for a second time to high altitude after 7 days at low altitude (SL, ALT1, 7 and 16 and POST time points in Supplementary Table S1 ). Relative ion counts (integrated peak areas of extracted ion chromatograms for each metabolite) are provided, together with KEGG pathway compound IDs, pathway names (color coded, in agreement with the legend at the bottom of the table), the experimental mass to charge ratios and retention times, and the polarity in which each metabolite has been assayed. Elaboration files for PLS-DA, HCA and ANOVA are included in Supplementary Table S1 and S2, and the results of both statistical analyses are plotted in Figure 1 .A and B, respectively. PLS-DA of RBC metabolic profiles clearly discriminated the sample groups across two main principal components (PCs) (Figure 1 .A). The top ten metabolites (loading variables) contributing to the PLS-DA clustering pattern are highlighted in Figure 1 .B, and include metabolites involved in energy metabolism (adenosine triphosphate -ATP, bisphosphoglcyerate -BPG), glutathione homeostasis (glutathione -GSH, cysteine-glycine, gamma-glutamate), and polyamines (spermidine, putrescine). HCA highlighted three main trends for metabolite relative abundances during adaptation, including (i) metabolites that accumulate during adaptation (blue to red); (ii) metabolites that transiently increase (blue-red-blue); and (iii) metabolites that decrease following exposure to hypoxia (red to blue -from top to bottom, left to right in Figure 1 .B, extended version in Supplementary Figure S1 ).
To ease data interpretation, metabolites showing statistically significant changes (q<0.05 ANOVA) in at least one time point compared to SL measurements were grouped by pathway in 
Glycolysis and Pentose Phosphate Pathway
Glycolytic precursor glucose 6-phosphate accumulated from day 1 to 7, and decreased again from day 7 to 16. On the other hand, late glycolytic end products downstream of triose phosphates (glyceraldehyde 3-phosphate) accumulated significantly on day 1. Decreases in phosphoglycerate and phosphoenolpyruvate and increases in pyruvate and lactate are suggestive of rapid fluxing through glycolysis in response to hypoxia (Figure 2 ). In parallel, we observed decreases in the levels of oxidative phase metabolites of the PPP (6-phosphogluconolactone and 6-phosphogluconate - Figure 1 ).
Amino acids, glutathione homeostasis and transamination
Despite depression of PPP (Figure 2 ), hypoxia promoted GSH accumulation and oxidized glutathione (GSSG) depletion, consistent with reduced oxidative stress or increased de novo biosynthesis (also supported by the progressive depletion of GSH precursors glutamine/ glutamate and cysteine - Figure 3 ). Glutamate depletion might be influenced by increased transamination of pyruvate (an accumulating byproduct of glycolysis - Figure 2 ) into alanine ( Figure 3 ).
Nitrogen metabolism
Partially functional urea cycle metabolism is present in mitochondria-devoid RBCs, [45] [46] [47] as well as a functional nitric oxide synthase 48 , that competes with arginase for the substrate Larginine to generate nitric oxide (NO) under ischemic/reperfusion conditions in RBCs 49 . Of note, in human lung endothelial cells, arginase is upregulated by hypoxia 50 . Arginine was consumed without accumulation of urea cycle intermediates (citrulline levels oscillated after early significant increases at ALT1, while ornithine levels increased significantly only in POST samples). At the same time, polyamine accumulation was observed transiently at ALT7 (spermidine, spermine). Asymmetric dimethyl-arginine increased after one week and sixteen days ( Figure 4 ). Early arginine consumption, polyamine accumulation at intermediate time points and urea cycle activation after desecent/renascent were observed (Figure 4 ). Nitrite and nitrate levels increased at ALT1 and ALT16 in comparison to baseline sea level (p<0.01 and 0.001, respectively - Figure 4 ). Higher than baseline nitrite and nitrate levels were retained after reascending.
Altered purine homeostasis was also mirrored by the significant accumulation of adenine, adenosine, hypoxanthine and nicotinamide proportionally to the duration of exposure to high altitude ( Figure 4 ).
Arginine and sulphur metabolism
Arginine consumption could also be tied to the observed increase in creatine metabolism, as confirmed by the accumulation of creatine, creatinine and phosphocreatine before descent after ALT16 ( Figure 5 ). While arginine catabolism might contribute to nitric oxide (NO) homeostasis, additional vasodilation mechanisms can possibly be explained by decreased levels of taurine/hypotaurine ( Figure 5 ) together with cysteine consumption (Figure 4 ) to mirror altered function of H 2 S-generating pathways.51 Direct measurements of hydrogen sulfide (H 2 S) showed significant decreases after exposure to high altitude hypoxia, and H 2 S levels remained significantly lower than baseline values during the second reascent (p<0.0001 - Figure 5 ).
Correlation with physiological parameters
Within the framework of the AltitudeOmics project, physiological, athletic performance and reaction time tests were performed at either sea level, 1 and 16 days at high altitude. 15, [33] [34] [35] [36] [37] [38] [39] Here we correlated raw metabolomics data for each metabolite in each biological replicate at SL, ALT1 and 16 to other data available for each subject (Supplementary Table S3 ). Linear correlation values (r) were used to perform HCA (Supplementary Figure S2) with the goal of highlighting a core set of metabolites and physiological/athletic parameters that show strong correlations (> |0.6|). The strongest correlations were selected and plotted in Figure 6 , and highlight a high correlation of metabolite levels to gaseous measurements (PaO 2 , PaCO 2 ) especially for the PPP final product ribose phosphate and sphingosine 1-phosphate.
Metabolite levels were correlated among each other at each time point (including SL, ALT1, 7 and 16 and POST - Figure 7) . As a result, highest significant correlations (p<0.0001, ~0.7<r<0.99) were observed between several metabolites and, in particular, for trioses (glyceraldehyde 3-phosphate, phosphoglycerate), purine metabolites (adenosine, adenosine monophosphate -AMP) and metabolites involved in glutathione homeostasis (5-oxoproline, glutamate - Figure 7) .
We thus calculated the sum of the absolute values of linear correlations for all metabolites and physiological values ( Figure 7 ). This elaboration has been thought to suggest whether a set of metabolites with the highest total correlative values with other metabolites and physiological parameters might be regarded as key players in RBC metabolic adaptations to high altitude hypoxia. Results further indicated a preminent role for glyceraldehyde 3-phosphate, ribose phosphate and adenosine ( Figure 7 ).
Discussion
The present study is part of the AltitudeOmics research program, a project that was designed to gain insights into adaptation to hypoxia and the retention of adaptation after return to low altitude through the study of physiological and metabolomics responses. This project involved twenty-one lowland volunteers in the field who were taken rapidly to 5260 m, where they acclimatized for 16 days. They then descended to 1525 m for 7 days, after which they returned quickly to 5260 m and were retested for physiological, behavioral, and physical parameters, as previously published. 15, [33] [34] [35] [36] [37] [38] [39] In parallel to these tests, RBC samples were collected at sea level (baseline), after 1, 7 and 16 days at high altitude, and following reascent after 7 days living at 1525m.
In the present study, we seek to investigate whether RBCs, key players in oxygen transport/ delivery and a sink for the plasma metabolome, are metabolically influenced by exposure to high altitude hypoxia. This hypothesis was formulated in the light of in vitro evidence showing the presence of an oxygen-dependent metabolic modulation in RBCs. [26] [27] [28] [29] [30] Such adaptive mechanism results in the accumulation of NADPH for anti-oxidant purposes through the PPP under high oxygenation, since late glycolytic enzymes are sequestered (inhibitory binding) at the level of the cytosolic domain of band 3 and metabolic fluxes through the Embden-Meyerhof pathway are depressed. On the other hand, under low oxygenation, deoxyhemoglobin binding to the N-terminal cytosolic domain of band 3 displaces bound/inhibited glycolytic enzymes, thus promoting glycolysis and DPG generation, which in turn stabilizes the T state of hemoglobin. Ongoing glycolysis also promotes intracellular acidification. Increased proton availability thus favors the protonation of distal histidine and other key residues under deoxygenation, 52 resulting in oxygen offloading, a phenomenon referred to as the "Bohr effect". While these metabolic adaptations have been consolidated through laboratory studies over the years, in vivo metabolomics evidence has not been generated yet, especially on a rare sample set such as lowlanders Here we confirmed for the first time that exposure to hypoxia results in an immediate enhancement of glycolysis and shut down of PPP in vivo in humans (a few hours after exposure on day 1), as evidenced by the significant and progressive accumulation of key triose phosphates and late glycolytic byproducts. However, while hypoxia is supposed to limit the antioxidant potential of RBCs in vitro 30 and promote oxidative/reductive oxidative and nitrosative stress at high altitude, 57 here we show that RBC metabolic adaptations to hypoxia in vivo result in higher levels of GSH and decreased GSSG. This finding is either suggestive of decreased oxidative stress or increased de novo biosynthesis of GSH, an ATPdependent phenomenon 58 that could be favored by transient increases of ATP levels during early responses observed on day 1 to 7, consistent with recent observations on anaerobically stored erythrocyte concentrates for transfusion purposes. 59 This adaptation is notably lost at the POST time point, which showed a decrease in GSH levels and an increase in GSSG levels mirroring increased oxidative stress associated with transient re-exposure to normoxia.
Higher availability of ATP also resulted in the accumulation of AMP and adenosine, which in the light of the progressive accumulation of the non-oxidative phase PPP product ribose phosphate, is suggestive of ongoing phosphoribolysis. This effect is relevant in that circulating purines are known to stimulate coronary vasodilation 60 in a nitric oxideindependent fashion, 61 through targeting of specific receptors such as adenosine A(2B). 62, 63 Together with the accumulation of hypoxanthine, an adenine deamination byproduct that does not contribute to adenosine-induced coronary vasodilation 64 , these results are consistent with recent observations suggesting a mechanistic role for the purinergic system in driving RBC metabolic adaptations to hypoxia. 63 Moreover, RBC xanthine oxidoreductase has been implicated in the erythrocytic activation of nitrite homeostasis 65 . Though follow-up targeted studies are mandatory to elucidate the regulatory mechanisms triggered by purine metabolites during adaptation to hypoxia, this hypothesis is further supported by correlative analyses showing a strong metabolic linkage between purine metabolites and triose phosphates generated by late glycolysis. In this view, it should be further noted that other purine analogues such as caffeine, a xanthine alkaloid, have been questioned to either have a beneficial or deleterious effect on adaptative responses (e.g. vasodilation). 66 Nitric oxide-generating pathways (arginine catabolism and citrulline accumulation) were apparently upregulated upon early exposure to hypoxia, but were down-regulated after 7 days at high altitude, consistent with the hereby observed increase in asymmetric dimethylarginine, a nitric oxide synthase inhibitor. 67 Of note, significant nitrite and nitrate increase were observed after 1 and 16 days at high altitude, and were preserved at the time of reascending one week after returning to 1525 m. Inorganic anions nitrate and nitrite were previously thought to be inert end products of endogenous nitric oxide (NO) metabolism. 68 However, NO 3 − and NO 2 − can be recycled in vivo to form NO, a phenomenon mediated by xanthine oxidorectuase, ascorbate, polyphenols, myoglobins and protons or, in RBCs, by deoxyhemoglobin 68 . NO generation through reduction of nitrite by RBCs and deoxyhemoglobin promotes hypoxic vasodilation, inhibition of platelet reactivity through the activation of cGMP signaling. [69] [70] [71] [72] [73] 74 Our observations are thus consistent with the hypothesis that these anions might represent an important alternative source of NO to the classical L-arginine-NO-synthase pathway, in particular in hypoxic states. 68 Arginine consumption could be also interpreted in the light of increases in creatine anabolism, especially after 7 and 16 days at high altitude. These results might indirectly mirror analogies between RBC metabolic adaptations to hypoxia and the role of the creatine pool and the quick availability of phosphocreatine in particular as a fast-mobilizing energy source for anaerobic activity in the muscle. In support of this finding, creatine supplementation has beneficial neuroprotective effects against transient cerebral hypoxiaischemia in rats. 75 These results are consistent with improved athletic performances of the AltitudeOmics subjects following 16 days at high altitude, 33 even though it will be important to evaluate metabolic adaptations to high altitude hypoxia in relation to this pathway within the context of muscle metabolism.
Consumption of thiol/sulphur containing compounds cysteine, taurine and hypotaurine are here suggestive of alterations of sulphur metabolism during adaptation to hypoxia. In the absence of flux analyses, decreased levels of these compounds as seen here might either indicate increased consumption or decreased biosynthesis. An inhibitory effect of hydrogen sulfide (H 2 S) on hypoxia-inducible factor 1 (HIF1) in response to hypoxia has been previously reported. 76 H 2 S is a RBC catabolic byproduct of sulphur-containing metabolites and a vasorelaxing molecule modulating vascular blood flow and pressure. 51 Consistently, exposure to high altitude resulted in immediate decreases in H 2 S, an adaptation that was preserved after one week at 1525m.
Correlative analyses indicated a linkage between triose phosphates, pentose phosphate, sphingosine signaling and adaptive responses to hypoxia affecting physical performances, including gas transport (e.g. PaO 2 , PaCO 2 ). Even though correlation does not imply causation, it is worthwhile to stress how metabolic reprogramming correlates with oxygen and CO 2 homeostasis, two key variables mediating acclimatization to high altitude hypoxia. However, direct correlations with physical performance parameters >|0.5| were not observed. Of note, sphingosine kinase is a target of HIF signaling and participates in angiogenesis signaling to improve responses to hypoxia 77, 78 . Overall, correlative results are indicative of "metabolic linkages" between pathways, such as glycolysis and salvage reactions. The current analysis also expands upon current knowledge of RBC metabolism, and the intertwinement of specific metabolic pathway adaptations within hours of exposure to hypoxia in vivo. Of note, these results inform about the preservation ("metabolic memory") of such adaptations after one week from descent to lower altitudes, when other physiologic adaptations (higher hematocrit and hemoglobin levels 12 ) are no longer retained, despite the persistence of measurable advantages in physical activity performances. 33 . In this view it is worth noting that also not all metabolic adaptations are retained after a second reascent, such as for example those related to the total levels of reduced glutathione, polyamines, creatine and carnitine metabolism. This is relevant in that it suggests that some of these metabolic adaptations observed during prolonged exposure to high altitude hypoxia may be a secondary effect of the main adaptations (e.g. glycolysis/PPP ratios, purine metabolism, nitrogen and hydrogen sulphide metabolism) that are actually needed to drive improved oxygen delivery and physical performances. Alternatively, some of these adapations may be necessary to compensate up/down-regulation of other pathways immediately after exposure to hypoxia(e.g. carnitine and creatine metabolism in energy/nitrogen metabolism), a mechanism that becomes unnecessary after acclimatization is established. Alternatively, this observation may rather indicate that prolonged and continuous stimuli are necessary to retain changes in those pathways that are restored to pre-ascent level upon transient descent to lower altitudes.
Conclusion
Here we applied metabolomics technologies to investigate the metabolic adaptation of human RBCs to high altitude hypoxia. The results impact the understanding of RBC responses to hypoxia in vivo, a basic biological question that expands beyond the scope of altitude research and into the fields of cardiovascular, 1 polmunology 2 , trauma/hemorrhagic shock-induced hypoxemia 4 , and transfusion medicine 3 . We provide for the first time supportive evidence of RBC metabolic adaptations (bottom right panel - Figure 7 ) that ensue within hours from exposure to high altitude hypoxia.
Increases in glycolysis and deregulation of PPP was observed in RBCs from human volunteers ascending to 5260m, consistent with well-established in vitro models of oxygendependent metabolic modulation in human RBCs [26] [27] [28] [29] . However, antioxidant potential in human RBCs was not limited by tuning down of PPP. Indeed, increased levels of the glutathione pool and decreased levels of precursor amino acids are suggestive of increased de novo synthesis of reducing equivalents. Arginine metabolism fueled the early accumulation of nitrite and nitrate (oxidation products of NO and a sink for NO generation under hypoxia). Arginine catabolism also corresponded to increases in the creatine pool, mirroring potential metabolic adaptations in muscles where increases in the creatine pool provide fast mobilizable energy sources to fuel physical activity under hypoxic conditions. Alterations to sulphur metabolism, as mirrored by altered levels of taurine, hypotaurine, cysteine and methionine, paralleled the observed adaptive deregulation of H 2 S in response to hypoxia. Finally, we provide the first in vivo evidence of the metabolic centrality of purines, triose and pentose phosphates, and sphingosine 1-phosphate in RBCs from volunteers exposed to high altitude hypoxia. We present correlative evidence between the levels of these metabolites and improved physiological parameters upon adaptation to hypoxia, such as gas transport, substantiating a role for metabolic modulation as an avenue to improve adaptive responses to hypobaric hypoxia.
Finally, we show that, contrary to other transient physiological adaptations (hematocrit and hemoglobin levels 33 ), metabolic adaptations are retained after descending to lower altitude for one week, consistent with improved physical performance. each metabolite against other metabolites and physiological parameters. Results were thus sorted to obtain a rank of metabolites with the highest total correlations with other metabolites and physiological parameters, indicating their centrality in metabolic adaptations to hypoxia. The bottom right panel summarizes the main metabolic adaptations observed in RBCs after acute and chronic exposure to high altitude hypoxia. Pathways are color-coded and arrow widths indicate relative fluxes through the pathway.
